Literature DB >> 1867349

Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria.

J K Baird1, T R Jones, E W Danudirgo, B A Annis, M J Bangs, H Basri, S Masbar.   

Abstract

An epidemiologic study of susceptibility to frequent and high-grade parasitemia by Plasmodium falciparum revealed that age-dependent acquired protection developed within a two-year period of exposure to hyperendemic infection pressure. The study was conducted in a single village in northeastern Irian Jaya, Indonesia, where half the residents were native to the province and the other half were transmigrants from areas of Java, where there is little or no malaria transmission. Five separate measures of susceptibility to the asexual parasitemia of falciparum malaria were derived from results of four months of biweekly surveillance of 240 volunteers. Increasing protection as a function of age among the Javanese was a consistent pattern among the five estimates of susceptibility. These age-dependent functions of protection were quantitatively parallel to those among life-long residents of Irian Jaya. When humoral immune responsiveness to ring-infected erythrocyte surface antigen (RESA) was measured by ELISA, a similar pattern emerged; the relative level of antibody to RESA increased as parallel functions of age among the two subpopulations. Acquired protective immunity against P. falciparum was not the cumulative product of many years of heavy exposure to antigen. Instead, the full benefit of protection appeared to develop quickly. The degree of protection was governed by recent exposure and age, independent of history of chronic heavy exposure.

Entities:  

Mesh:

Year:  1991        PMID: 1867349     DOI: 10.4269/ajtmh.1991.45.65

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  47 in total

1.  Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.

Authors:  D Dodoo; T G Theander; J A Kurtzhals; K Koram; E Riley; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations.

Authors:  Michelle J Boyle; Prasanna Jagannathan; Katherine Bowen; Tara I McIntyre; Hilary M Vance; Lila A Farrington; Bryan Greenhouse; Felistas Nankya; John Rek; Agaba Katureebe; Emmanuel Arinaitwe; Grant Dorsey; Moses R Kamya; Margaret E Feeney
Journal:  J Infect Dis       Date:  2015-02-02       Impact factor: 5.226

Review 3.  Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies.

Authors:  Mônica da Silva-Nunes; Marta Moreno; Jan E Conn; Dionicia Gamboa; Shira Abeles; Joseph M Vinetz; Marcelo U Ferreira
Journal:  Acta Trop       Date:  2011-10-12       Impact factor: 3.112

4.  Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Authors:  Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 6.  Advances and challenges in malaria vaccine development.

Authors:  Peter D Crompton; Susan K Pierce; Louis H Miller
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 7.  Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Authors:  Silvia Portugal; Susan K Pierce; Peter D Crompton
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

8.  Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum.

Authors:  E Scarselli; R Tolle; O Koita; M Diallo; H M Müller; K Früh; O Doumbo; A Crisanti; H Bujard
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 9.  Evolutionary and historical aspects of the burden of malaria.

Authors:  Richard Carter; Kamini N Mendis
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon.

Authors:  Bruno Bezerril Andrade; Bruno Coelho Rocha; Antonio Reis-Filho; Luís Marcelo Aranha Camargo; Wanderli Pedro Tadei; Luciano Andrade Moreira; Aldina Barral; Manoel Barral-Netto
Journal:  Malar J       Date:  2009-06-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.